LinkedIn fatally losing Russian audience — IT watchdogBusiness & Economy September 26, 21:26
Topol ballistic missile test launched from range in Russia's southMilitary & Defense September 26, 19:59
Greek airline Ellinair ready to repatriate VIM-Avia passengers at its own expenseBusiness & Economy September 26, 19:04
Toro Rosso confirms Pierre Gasly to stand in for Daniil Kvyat for Malaysian Grand PrixSport September 26, 18:41
Russian Foreign Ministry says there is no legal ban on Iran’s missile testsRussian Politics & Diplomacy September 26, 18:38
Remote city in Russia's Arctic receives fiber optic link to InternetBusiness & Economy September 26, 18:29
US Senate Committee approves Huntsman as ambassador to RussiaWorld September 26, 18:17
Twitter pledges to move personal data of users to Russia by 2018Business & Economy September 26, 18:15
Putin relieves Russian Aerospace commander-in-chief of his dutiesRussian Politics & Diplomacy September 26, 17:57
MOSCOW, December 23. /TASS/. An experimental Ebola vaccine proved to be highly protective against the deadly virus in a major trial in Guinea, the World Health Organization announced in a statement Friday.
"While these compelling results come too late for those who lost their lives during West Africa's Ebola epidemic, they show that when the next Ebola outbreak hits, we will not be defenceless," said Dr Marie-Paule Kieny, WHO’s Assistant Director-General for Health Systems and Innovation, who is also the study’s lead author.
The vaccine, called rVSV-ZEBOV, was studied in a trial involving 11,841 people in Guinea during 2015. Among the 5,837 people who received the vaccine, no Ebola cases were recorded 10 days or more after vaccination. In comparison, there were 23 cases 10 days or more after vaccination among those who did not receive the vaccine.
The vaccine was manufactured by Merck, Sharpe & Dohme (MSD).
According to the WHO, more than 11,000 people died during the 2014-2015 Ebola outbreak in West Africa. Most fatalities occurred in Liberia, Sierra-Leone and Guinea.